Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.

Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, Schmidt MK, Markowitz S, Yan H, Bigner D, Hruban RH, Eshleman JR, Iacobuzio-Donahue CA, Goggins M, Maitra A, Malek SN, Powell S, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N.

Hum Mutat. 2012 Jan;33(1):100-3. doi: 10.1002/humu.21633. Epub 2011 Nov 23.

PMID:
22009941
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.

Horlings HM, Lai C, Nuyten DS, Halfwerk H, Kristel P, van Beers E, Joosse SA, Klijn C, Nederlof PM, Reinders MJ, Wessels LF, van de Vijver MJ.

Clin Cancer Res. 2010 Jan 15;16(2):651-63. doi: 10.1158/1078-0432.CCR-09-0709. Epub 2010 Jan 12.

PMID:
20068109
[PubMed - indexed for MEDLINE]
Free Article
3.

The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis.

Wertheim GB, Yang TW, Pan TC, Ramne A, Liu Z, Gardner HP, Dugan KD, Kristel P, Kreike B, van de Vijver MJ, Cardiff RD, Reynolds C, Chodosh LA.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15855-60. doi: 10.1073/pnas.0906993106. Epub 2009 Aug 28.

PMID:
19717424
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.

van de Vijver M, Bilous M, Hanna W, Hofmann M, Kristel P, Penault-Llorca F, Rüschoff J.

Breast Cancer Res. 2007;9(5):R68.

PMID:
17922920
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy.

Hannemann J, Kristel P, van Tinteren H, Bontenbal M, van Hoesel QG, Smit WM, Nooij MA, Voest EE, van der Wall E, Hupperets P, de Vries EG, Rodenhuis S, van de Vijver MJ.

Br J Cancer. 2006 Nov 20;95(10):1334-41. Epub 2006 Oct 31.

PMID:
17088909
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.

Clin Cancer Res. 2006 Oct 1;12(19):5705-12.

PMID:
17020974
[PubMed - indexed for MEDLINE]
Free Article
7.

Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer.

Faneyte IF, Kristel PM, van de Vijver MJ.

Anticancer Res. 2004 Sep-Oct;24(5A):2931-9.

PMID:
15517899
[PubMed - indexed for MEDLINE]
Free Article
8.

Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.

Anninga JK, van de Vijver MJ, Cleton-Jansen AM, Kristel PM, Taminiau AH, Nooij M, Egeler RM, Hogendoorn PC.

Eur J Cancer. 2004 May;40(7):963-70.

PMID:
15093570
[PubMed - indexed for MEDLINE]
9.

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

Robanus-Maandag EC, Bosch CA, Kristel PM, Hart AA, Faneyte IF, Nederlof PM, Peterse JL, van de Vijver MJ.

J Pathol. 2003 Sep;201(1):75-82.

PMID:
12950019
[PubMed - indexed for MEDLINE]
10.

Expression of the breast cancer resistance protein in breast cancer.

Faneyte IF, Kristel PM, Maliepaard M, Scheffer GL, Scheper RJ, Schellens JH, van de Vijver MJ.

Clin Cancer Res. 2002 Apr;8(4):1068-74.

PMID:
11948115
[PubMed - indexed for MEDLINE]
Free Article
11.

Determining MDR1/P-glycoprotein expression in breast cancer.

Faneyte IF, Kristel PM, van de Vijver MJ.

Int J Cancer. 2001 Jul 1;93(1):114-22.

PMID:
11391630
[PubMed - indexed for MEDLINE]
12.

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M.

Nat Genet. 2000 Nov;26(3):291-9.

PMID:
11062467
[PubMed - indexed for MEDLINE]
13.

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.

Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ.

Arch Otolaryngol Head Neck Surg. 1997 May;123(5):497-502.

PMID:
9158396
[PubMed - indexed for MEDLINE]
14.

Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit.

Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der Burg B, Michalides RJ.

Mol Cell Biol. 1996 Jun;16(6):2554-60.

PMID:
8649362
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Expression of a functional thyroglobulin fragment in a baculovirus system.

den Hartog MT, Sijmons CC, Kristel PM, Bakker O, de Vijlder JJ.

J Mol Endocrinol. 1993 Oct;11(2):161-6.

PMID:
8297472
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk